中国医药科学Issue(20)：21-23,3.
雷帕霉素免疫抑制和抗肿瘤双重效应的研究进展
Advance research of rapamycin between immunosuppression and antitumor effect
傅云峰 1刘竞1
作者信息
- 1. 中南大学湘雅三医院血液内科，湖南长沙 410013
- 折叠
摘要
Abstract
Rapamycin (RAPA) is a kind of macrolide antibiotics. Initially it is widely used in clinical as a potent immunosuppressant, which not only has a significant curative effect on a variety of autoimmune diseases, but also shows a good anti-rejectin in organ transplantation and less side effects .In recent years, it's found RAPA has anti-tumor effect, which is a sort of drugs that owning the dual role of immunosuppressive and antitumor. In this paper, the progress of RAPA in the treatment of common diseases for the dual pharmacological effects is reviewed.关键词
雷帕霉素/免疫抑制剂/抗肿瘤Key words
Rapamycin/Immunosuppressant/Antitumor分类
医药卫生引用本文复制引用
傅云峰,刘竞..雷帕霉素免疫抑制和抗肿瘤双重效应的研究进展[J].中国医药科学,2013,(20):21-23,3.
